Exosomal miRNA-215-5p Derived from Adipose-Derived Stem Cells Attenuates Epithelial–Mesenchymal Transition of Podocytes by Inhibiting ZEB2

Background. Podocyte migration is actively involved in the process of podocyte loss and proteinuria production, which is closely associated with the development of diabetic nephropathy (DN). Exosomes from adipose-derived stem cells (ADSCs-Exos) effectively inhibit podocyte apoptosis in the treatment...

Full description

Bibliographic Details
Main Authors: Juan Jin, Yunguang Wang, Li Zhao, Wenli Zou, Mingming Tan, Qiang He
Format: Article
Language:English
Published: Hindawi Limited 2020-01-01
Series:BioMed Research International
Online Access:http://dx.doi.org/10.1155/2020/2685305
id doaj-83760510cb8e4835bf08d92e7eef7d73
record_format Article
spelling doaj-83760510cb8e4835bf08d92e7eef7d732020-11-25T02:11:43ZengHindawi LimitedBioMed Research International2314-61332314-61412020-01-01202010.1155/2020/26853052685305Exosomal miRNA-215-5p Derived from Adipose-Derived Stem Cells Attenuates Epithelial–Mesenchymal Transition of Podocytes by Inhibiting ZEB2Juan Jin0Yunguang Wang1Li Zhao2Wenli Zou3Mingming Tan4Qiang He5Department of Nephrology, Zhejiang Provincial People’s Hospital, Zhejiang 310014, ChinaInstitute of Nuclear-Agricultural Sciences, Zhejiang University, Hangzhou, 310058 Zhejiang, ChinaDepartment of Nephrology, Zhejiang Provincial People’s Hospital, Zhejiang 310014, ChinaDepartment of Nephrology, Zhejiang Provincial People’s Hospital, Zhejiang 310014, ChinaPeople’s Hospital of Hangzhou Medical College, Zhejiang 310014, ChinaDepartment of Nephrology, Zhejiang Provincial People’s Hospital, Zhejiang 310014, ChinaBackground. Podocyte migration is actively involved in the process of podocyte loss and proteinuria production, which is closely associated with the development of diabetic nephropathy (DN). Exosomes from adipose-derived stem cells (ADSCs-Exos) effectively inhibit podocyte apoptosis in the treatment of DN. However, how ADSCs-Exos affect the migration of podocytes is obscure. This study is aimed at exploring the regulatory role of ADSCs-Exos on cell migration and the underlying mechanism. Methods. ADSCs-Exo was authenticated by transmission electron microscopy (TEM), western blotting, and flow cytometry. Cell viability and migration ability of podocytes were measured by CCK8 and Transwell assays, respectively. Relative expressions of miRNAs and mRNAs were determined by qRT-PCR. The transmitting between PKH26-labeled exosome and podocytes was evaluated by IF assay. Dual luciferase reporter assay was employed to detect the relationship between miR-215-5p and ZEB2. Results. The exposure to serum from DN patient (hDN-serum) significantly inhibited cell viability of podocytes, but ADSCs-Exo addition notably blunts cytotoxicity induced by the transient stimulus of hDN-serum. Besides, ADSCs-Exo administration powerfully impeded high glucose- (HG-) induced migration and injury of podocyte. With the podocyte dysfunction, several miRNAs presented a significant decline under the treatment of HG including miR-251-5p, miR-879-5p, miR-3066-5p, and miR-7a-5p, all of which were rescued by the addition of ADSCs-Exo. However, only miR-251-5p was a key determinant in the process of ADSCs-Exo-mediated protective role on podocyte damage. The miR-251-5p inhibitor counteracted the improvement from the ADSCs-Exo preparation on HG-induced proliferation inhibition and migration promotion. Additionally, miR-215-5p mimics alone remarkably reversed HG-induced EMT process of podocyte. Mechanistically, we confirmed that ADSCs-Exos mediated the shuttling of miR-215-5p to podocyte, thereby protecting against HG-induced metastasis, possibly through inhibiting the transcription of ZEB2. Conclusion. ADSCs-Exo has the protective effect on HG-evoked EMT progression of podocytes thru a mechanism involving ZEB2. Potentially, the ADSCs-Exo preparation is a useful therapeutic strategy for improving podocyte dysfunction and DN symptoms clinically.http://dx.doi.org/10.1155/2020/2685305
collection DOAJ
language English
format Article
sources DOAJ
author Juan Jin
Yunguang Wang
Li Zhao
Wenli Zou
Mingming Tan
Qiang He
spellingShingle Juan Jin
Yunguang Wang
Li Zhao
Wenli Zou
Mingming Tan
Qiang He
Exosomal miRNA-215-5p Derived from Adipose-Derived Stem Cells Attenuates Epithelial–Mesenchymal Transition of Podocytes by Inhibiting ZEB2
BioMed Research International
author_facet Juan Jin
Yunguang Wang
Li Zhao
Wenli Zou
Mingming Tan
Qiang He
author_sort Juan Jin
title Exosomal miRNA-215-5p Derived from Adipose-Derived Stem Cells Attenuates Epithelial–Mesenchymal Transition of Podocytes by Inhibiting ZEB2
title_short Exosomal miRNA-215-5p Derived from Adipose-Derived Stem Cells Attenuates Epithelial–Mesenchymal Transition of Podocytes by Inhibiting ZEB2
title_full Exosomal miRNA-215-5p Derived from Adipose-Derived Stem Cells Attenuates Epithelial–Mesenchymal Transition of Podocytes by Inhibiting ZEB2
title_fullStr Exosomal miRNA-215-5p Derived from Adipose-Derived Stem Cells Attenuates Epithelial–Mesenchymal Transition of Podocytes by Inhibiting ZEB2
title_full_unstemmed Exosomal miRNA-215-5p Derived from Adipose-Derived Stem Cells Attenuates Epithelial–Mesenchymal Transition of Podocytes by Inhibiting ZEB2
title_sort exosomal mirna-215-5p derived from adipose-derived stem cells attenuates epithelial–mesenchymal transition of podocytes by inhibiting zeb2
publisher Hindawi Limited
series BioMed Research International
issn 2314-6133
2314-6141
publishDate 2020-01-01
description Background. Podocyte migration is actively involved in the process of podocyte loss and proteinuria production, which is closely associated with the development of diabetic nephropathy (DN). Exosomes from adipose-derived stem cells (ADSCs-Exos) effectively inhibit podocyte apoptosis in the treatment of DN. However, how ADSCs-Exos affect the migration of podocytes is obscure. This study is aimed at exploring the regulatory role of ADSCs-Exos on cell migration and the underlying mechanism. Methods. ADSCs-Exo was authenticated by transmission electron microscopy (TEM), western blotting, and flow cytometry. Cell viability and migration ability of podocytes were measured by CCK8 and Transwell assays, respectively. Relative expressions of miRNAs and mRNAs were determined by qRT-PCR. The transmitting between PKH26-labeled exosome and podocytes was evaluated by IF assay. Dual luciferase reporter assay was employed to detect the relationship between miR-215-5p and ZEB2. Results. The exposure to serum from DN patient (hDN-serum) significantly inhibited cell viability of podocytes, but ADSCs-Exo addition notably blunts cytotoxicity induced by the transient stimulus of hDN-serum. Besides, ADSCs-Exo administration powerfully impeded high glucose- (HG-) induced migration and injury of podocyte. With the podocyte dysfunction, several miRNAs presented a significant decline under the treatment of HG including miR-251-5p, miR-879-5p, miR-3066-5p, and miR-7a-5p, all of which were rescued by the addition of ADSCs-Exo. However, only miR-251-5p was a key determinant in the process of ADSCs-Exo-mediated protective role on podocyte damage. The miR-251-5p inhibitor counteracted the improvement from the ADSCs-Exo preparation on HG-induced proliferation inhibition and migration promotion. Additionally, miR-215-5p mimics alone remarkably reversed HG-induced EMT process of podocyte. Mechanistically, we confirmed that ADSCs-Exos mediated the shuttling of miR-215-5p to podocyte, thereby protecting against HG-induced metastasis, possibly through inhibiting the transcription of ZEB2. Conclusion. ADSCs-Exo has the protective effect on HG-evoked EMT progression of podocytes thru a mechanism involving ZEB2. Potentially, the ADSCs-Exo preparation is a useful therapeutic strategy for improving podocyte dysfunction and DN symptoms clinically.
url http://dx.doi.org/10.1155/2020/2685305
work_keys_str_mv AT juanjin exosomalmirna2155pderivedfromadiposederivedstemcellsattenuatesepithelialmesenchymaltransitionofpodocytesbyinhibitingzeb2
AT yunguangwang exosomalmirna2155pderivedfromadiposederivedstemcellsattenuatesepithelialmesenchymaltransitionofpodocytesbyinhibitingzeb2
AT lizhao exosomalmirna2155pderivedfromadiposederivedstemcellsattenuatesepithelialmesenchymaltransitionofpodocytesbyinhibitingzeb2
AT wenlizou exosomalmirna2155pderivedfromadiposederivedstemcellsattenuatesepithelialmesenchymaltransitionofpodocytesbyinhibitingzeb2
AT mingmingtan exosomalmirna2155pderivedfromadiposederivedstemcellsattenuatesepithelialmesenchymaltransitionofpodocytesbyinhibitingzeb2
AT qianghe exosomalmirna2155pderivedfromadiposederivedstemcellsattenuatesepithelialmesenchymaltransitionofpodocytesbyinhibitingzeb2
_version_ 1715548867019145216